APRE

Aprea Therapeutics, Inc.

SCoRE: 58

LAST PRICE - AT THE CLOSE

APRE is UP 13% since the begininning of the year

APRE is DOWN -1% BELOW 20 day SMA

APRE is UP 6% ABOVE 200 day SMA

View More APRE Price Action

PROFITABLE: NO
EPS: $-0.67

EARNINGS MOMENTUM: NO
0.12% DECREASE IN QTRLY EARNINGS

P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A

REVENUE IS: 964K

DEBT IS: N/A

CASH IS: 32M

	THE STOCK IS 99.5% AWAY FROM ALL-TIME HIGHS OF $1062.2
	APRE IS UP 13% SINCE THE BEGINNING OF THE YEAR
	APRE IS UP 45% OVER THE PAST 12 MONTHS
	APRE IS DOWN -1% OVER THE PAST 1 MONTH
	2% OF ALL APRE INVESTORS ARE BETTING AGAINST APRE
	NUM INVESTORS SHORT APRE HAS GONE UP N/A% VERSUS LAST MONTH